Search

Your search keyword '"Hachulla E"' showing total 3,218 results

Search Constraints

Start Over You searched for: Author "Hachulla E" Remove constraint Author: "Hachulla E"
3,218 results on '"Hachulla E"'

Search Results

4. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children

8. Atteinte musculaire au cours de la sclérodermie systémique : la mortalité n’est pas associée à la nature des lésions histologiques

10. POS0235 NEW ONSET OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: CLINICAL COURSE AND OUTCOMES FROM A EUSTAR DATABASE ANALYSIS

11. POS1258 STRATIFICATION OF SJÖGREN’S DISEASE, BASED ON SYMPTOMS, CLINICAL AND ROUTINE BIOLOGICAL DATA, IS SUPPORTED BY DISTINCT PATHOPHYSIOLOGICAL PATHWAYS

12. POS0211 PAH TREATMENT AT TIME OF DIAGNOSIS IS ASSOCIATED WITH IMPROVED SURVIVAL REGARDLESS OF HEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION - A EUSTAR ANALYSIS

13. POS1263 LYMPHOMA TREATMENT STRATEGY AFFECTS AUTOIMMUNE DISEASE ACTIVITY AND LYMPHOMA RELAPSE IN PATIENTS WITH SJÖGREN DISEASE AND MARGINAL ZONE LYMPHOMA

14. AB1251 PROGNOSIS OF ESSENTIAL MIXED CRYOGLOBULINEMIA AND CONNECTIVE TISSUE DISEASE-RELATED CRYOGLOBULINEMIA AFTER RITUXIMAB-INDUCED REMISSION

15. Prévalence et phénotype associé aux anticorps anti-Ro52-kDa/SSA (TRIM21) dans la sclérodermie systémique : données d’une cohorte française, revue de la littérature et méta-analyse

16. POS0700 SEVERE ENTEROVIRUS INFECTIONS IN PATIENTS WITH AUTOIMMUNE DISEASES RECEIVING ANTI-CD20 MONOCLONAL ANTIBODIES

17. OP0225 CHANGES IN TREATMENT PATTERNS AND THEIR INFLUENCE ON THE OUTCOME OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD) PATIENTS: AN EUSTAR ANALYSIS

21. OP0289 PREVALENCE OF ANTI-RO52-KDA/SSA (TRIM21) ANTIBODIES AND ASSOCIATED CLINICAL PHENOTYPE IN SYSTEMIC SCLEROSIS: DATA FROM A FRENCH COHORT, A SYSTEMATIC REVIEW AND META-ANALYSIS

24. Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry

25. Syndrome des antiphospholipides et hémorragie intra-alvéolaire : une étude française multicentrique et rétrospective

26. Étude nationale multicentrique sur l’utilisation du NINTEDANIB en vie réelle dans la PID-SSc

28. Tolérance et efficacité des thérapies ciblées prescrites pour des indications hors AMM dans les maladies auto-immunes systémiques réfractaires : données des 187 premiers patients inclus dans le registre TATA (TArgeted Therapy in Autoimmune Diseases)

29. Trajectoire d’ouverture buccale dans la sclérodermie systémique : une analyse longitudinale de 1101 patients issus de la cohorte française nationale

30. Présentation clinique, évolution et pronostic des patients atteints de connectivite mixte : une cohorte rétrospective multicentrique

31. Détermination de trois phénotypes distincts de la maladie de Sjögren associés à des pronostics différents par une analyse de cluster basée sur les manifestations cliniques et biologiques : données des cohortes Paris-Saclay et ASSESS

32. Cibler ccr4 avec le mogamulizumab dans le syndrome hyperéosinophilique réfractaire de variant lymphoïde CD3–CD4+

34. Les lymphomes compliquant la maladie de Sjögren sont associés à une accumulation de variations génétiques germinales sur des voies favorisant l’hyper-activation lymphocytaire B

36. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

37. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

41. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children

42. Infections sévères à entérovirus chez les patients traités par rituximab pour une maladie auto-immune : série de cas et revue de la littérature

44. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

45. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET

46. OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS

47. POS1283 HEART AND SYSTEMIC SCLEROSIS – FINDINGS FROM NATIONAL COHORT STUDY

49. POS0164 CHARACTERIZATION OF PULMONARY MANIFESTATIONS OF SJÖGREN SYNDROME: A MULTICENTER RETROSPECTIVE STUDY

50. POS1454 ARE ULTRASOUND SALIVARY PARENCHYMAL ABNORMALITIES MORE SEVERE IN PRIMARY SJÖGREN PATIENTS WITH A HIGHER DISEASE DURATION? A TRANSVERSAL INTERNATIONAL STUDY

Catalog

Books, media, physical & digital resources